Pfizer
235 East 42nd Street
New York, NY 10017
United States
Tel: (212) 733-2323
Website: https://www.pfizer.com/
5518 articles about Pfizer
-
Pfizer Inc. Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
11/19/2010
-
Pfizer Inc. Strikes $85M Deal With University of California, San Francisco (UCSF) to Develop Biotech Drugs
11/17/2010
-
Pfizer Inc.: Adding INSPRA(R) (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
11/15/2010
-
NHF: Allergic Reactions to rFIX and pdFIX Similar, Pfizer Inc. Study
11/15/2010
-
More Jobs Set to Go at Pfizer Inc.
11/15/2010
-
Avecia Biotechnology Inc. Has Engaged BioTechLogic as Consultants to Assist in Expanding Its Quality Management System (QMS) and in Preparing for Post Approval Manufacturing
11/15/2010
-
Merck & Co., Inc. Restarts Cholesterol Race Four Years After Pfizer Inc. Failure
11/11/2010
-
Pfizer Inc., Biovista Ink Pact to Find New Uses for Established Drugs
11/10/2010
-
GlaxoSmithKline and Pfizer Inc. Says Future IPO Possible For ViiV Healthcare
11/10/2010
-
Pfizer Inc.'s Wyeth Defeats Australian Generic Challenge Against Antidepressant Effexor Patent
11/9/2010
-
Ablynx Eligible for Milestone Payment as Pfizer Inc. Initiates Phase I Clinical Trial With a Second ANTI-TNF-alpha Nanobody
11/9/2010
-
Pfizer Inc.: In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function
11/8/2010
-
Datamonitor Report: Can Pfizer Inc. Rescue Hormonal Replacement Therapy?
11/8/2010
-
Athersys, Inc. Announces FDA Authorization of Phase II Clinical Trial for Inflammatory Bowel Disease With Pfizer Inc. Regenerative Medicine
11/8/2010
-
Pfizer Inc. Pill Leads Race to Dominate $12 Billion Rheumatoid Arthritis Market
11/5/2010
-
Pfizer Inc. Bone Drug, Fablyn Reduces Breast Cancer Risk in Older Women
11/5/2010
-
FDA Panels Vote on Safety of IV Seizure Drugs Dilantin, Made by Pfizer Inc.
11/4/2010
-
Pfizer Inc. Invites Public to View and Listen to Webcast of Presentation at Healthcare Conference
11/3/2010
-
Novartis AG's Onbrez Better Than Pfizer Inc.'s Drug Spiriva In COPD
11/3/2010
-
New Compounds May Treat Both Alcohol and Cigarette Addictions, Ernest Gallo Clinic and Research Center at University of California, San Francisco (UCSF) and Pfizer Inc. Study
11/3/2010